Blood cancers in indigenous populations: A global systematic review of incidence, mortality, and survival (1954-2024).
Indigenous peoples globally have worse blood cancer survival than non-Indigenous populations, with 90% of evidence from just four wealthy countries—urgent research gap.
This comprehensive global systematic review (n=126 articles, 16 countries, 1954-2024) confirms that Indigenous peoples worldwide consistently have poorer survival from leukemia, lymphoma, and myeloma compared to non-Indigenous populations, while 90% of evidence is concentrated in 4 high-income English-speaking countries. The systematic evidence gap for Indigenous populations in low-and-middle-income countries represents an urgent research priority.
What the study was
- Study design
- Global systematic review (PRISMA) — 126 articles, 16 countries, 70-year span
- Population
- Indigenous peoples globally with blood cancers (leukemia, lymphoma, myeloma), primarily from US, Canada, New Zealand, Australia
- Category
- Public Health
- Maturity
- Validated
- Journal
- Cancer Epidemiology
Why it surfaced
Systematic review demonstrating persistent global survival disparities for Indigenous peoples in blood cancers — major public health equity finding. Sentinel scan capture.
A plain-language summary of published research — not medical advice. Talk to a clinician about your own care.